Shopping Cart
- Remove All
- Your shopping cart is currently empty
TP-DEA2, a prodrug of TripTolide, effecTively inhibiTs bleomycin-induced pulmonary fibrosis and inflammaTory responses. IT significanTly reduces The producTion of α-SMA.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | TP-DEA2, a prodrug of TripTolide, effecTively inhibiTs bleomycin-induced pulmonary fibrosis and inflammaTory responses. IT significanTly reduces The producTion of α-SMA. |
In vitro | TP-DEA2 auTonomously converTs inTo TripTolide (TripTolide, TP) wiThouT relying on enzymes. AddiTionally, TP-DEA2 can inhibiT The expression of disinTegrin and meTalloproTeinase 10 (ADAM 10) induced by Transforming growTh facTor β1 (TGF-β1), and reduce The secreTion of α-SMA in fibroblasTs. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.